Updated: February 19, 2026
Nayzilam Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Get the latest Nayzilam shortage update for 2026. Learn what's causing supply issues and what patients can do to find this seizure rescue medication.
Nayzilam Shortage Update for 2026
If you rely on Nayzilam (Midazolam nasal spray) as a rescue medication for seizure clusters, staying informed about its availability is essential. In this article, we'll cover the current state of the Nayzilam supply, what's causing the shortage, and what you can do to protect yourself.
Current Supply Status
As of early 2026, Nayzilam continues to experience intermittent supply disruptions. Because it is manufactured by a single company — UCB Pharma — and has no generic equivalent, any interruption in production can quickly lead to shortages at pharmacies nationwide. Some patients report finding Nayzilam at specialty pharmacies while their local retail pharmacies remain out of stock.
For real-time availability, use MedFinder to check which pharmacies near you currently have Nayzilam in stock. You can also read our detailed guide: How to check if a pharmacy has Nayzilam in stock.
What's Causing the Shortage?
Several factors contribute to Nayzilam's availability challenges:
- Single-source manufacturing: UCB Pharma is the only company that makes Nayzilam. There are no authorized generic manufacturers.
- Supply chain pressures: Ongoing global supply chain issues can affect the availability of raw materials and packaging components needed to manufacture Nayzilam.
- Controlled substance regulations: As a Schedule IV medication, Nayzilam faces additional regulatory requirements that can slow distribution.
- Specialty pharmacy distribution: Nayzilam is often distributed through specialty pharmacy channels rather than regular wholesale distribution, which limits where it's available.
For more background, read our article: Why is Nayzilam so hard to find?
How to Protect Yourself During the Shortage
1. Refill Early
Request prescription refills well before your current supply runs out. Give yourself at least two to three weeks of lead time to account for any ordering delays or insurance processing.
2. Use MedFinder to Locate Stock
Visit MedFinder to search for pharmacies with Nayzilam in stock. This is faster and more reliable than calling individual pharmacies. For a full walkthrough, see how to find Nayzilam in stock near you.
3. Talk to Your Doctor About a Backup
Ask your neurologist to prescribe a backup rescue medication, such as Valtoco (Diazepam nasal spray) or Diastat. Having an alternative on hand ensures you're never completely without seizure rescue coverage.
4. Contact UCBCares
UCB Pharma offers patient support through UCBCares. They may be able to help you locate a pharmacy with stock or provide information about expected supply timelines.
5. Check Official Shortage Databases
The FDA Drug Shortage Database and the ASHP Drug Shortage Resource Center both track medication shortages. While updates may lag behind real-world availability, they provide official information about the scope and expected duration of shortages.
What About Insurance During a Shortage?
If your pharmacy can't fill your Nayzilam prescription due to a shortage, contact your insurance company. Many insurers will:
- Allow you to fill at an out-of-network pharmacy if your usual pharmacy is out of stock
- Waive prior authorization requirements during documented shortages
- Approve coverage for alternative medications like Valtoco
Document everything — keep records of pharmacy calls confirming the shortage, as this can help when appealing insurance decisions.
Looking Ahead
The long-term solution to Nayzilam availability issues would be the introduction of a generic version of Midazolam nasal spray or the approval of additional manufacturers. As of 2026, no generic Nayzilam has been approved, but this could change in the coming years as patent protections evolve.
In the meantime, staying proactive is your best defense. Keep your prescriptions current, maintain a backup rescue medication, and use tools like MedFinder to stay ahead of supply issues.
Resources
Frequently Asked Questions
Nayzilam has experienced intermittent supply disruptions in 2026 due to single-source manufacturing and supply chain challenges. Availability varies by pharmacy and location. Use MedFinder to check real-time stock near you.
The duration is uncertain. Because Nayzilam has only one manufacturer (UCB Pharma) and no generic version, supply disruptions may continue intermittently. Check the FDA Drug Shortage Database for official updates.
Many insurers will approve coverage for alternative seizure rescue medications like Valtoco during a documented shortage. Contact your insurance company and provide documentation that Nayzilam is unavailable at your pharmacy.
Check MedFinder (medfinder.com) for real-time pharmacy stock, the FDA Drug Shortage Database, and the ASHP Drug Shortage Resource Center for official updates on the Nayzilam supply situation.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsRelated articles
29,387 have already found their meds with Medfinder.
Start your search today.

![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)



